| Literature DB >> 34246454 |
Illias Tazi1, Fatima Zahra Lahlimi2.
Abstract
Lymphomas remain a leading cause of morbidity and mortality for HIV-positive patients. The most common lymphomas include diffuse large B-cell lymphoma, Burkitt lymphoma, primary effusion lymphoma, plasmablastic lymphoma and Hodgkin lymphoma. Appropriate approach is determined by lymphoma stage, performans status, comorbidities, histological subtype, status of the HIV disease and immunosuppression. Treatment outcomes have improved due to chemotherapy modalities and effective antiretroviral therapy. This review summarizes epidemiology, pathogenesis, pathology, and current treatment landscape in HIV associated lymphoma.Entities:
Keywords: AIDS; Antiretroviral therapy; HIV; Hodgkin lymphoma; Lymphome de Hodgkin; Lymphome non Hodgkinien; Non-Hodgkin's lymphoma; SIDA; Traitement antirétroviral; VIH
Year: 2021 PMID: 34246454 DOI: 10.1016/j.bulcan.2021.03.014
Source DB: PubMed Journal: Bull Cancer ISSN: 0007-4551 Impact factor: 1.276